(Q36898600)

16 August 2017

1 reference

title

Preclinical development of low toxicity drugs: focus on zanamivir, an anti-influenza drug (English)

1 reference

16 August 2017

1 reference

G D Dines

1

1 reference

16 August 2017

R Bethell

series ordinal

2

1 reference

16 August 2017

M Daniel

series ordinal

3

1 reference

16 August 2017

1 September 1998

1 reference

16 August 2017

1 reference

16 August 2017

19

1 reference

16 August 2017

3

1 reference

16 August 2017

233-241

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199819030-00006

16 August 2017

0 references

cites work

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

Serious morbidity and mortality associated with influenza epidemics

1 reference

12 December 2020

Pneumonia and influenza deaths during epidemics: implications for prevention

1 reference

12 December 2020

Assessing trends in mortality in 121 U.S. cities, 1970-79, from all causes and from pneumonia and influenza

1 reference

12 December 2020

Impact of epidemic type A influenza in a defined adult population

1 reference

12 December 2020

2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus

1 reference

12 December 2020

Two-year inhalation exposure of female and male B6C3F1 mice and F344 rats to chlorine gas induces lesions confined to the nose

1 reference

12 December 2020

Comparative pulmonary toxicities and carcinogenicities of chronically inhaled diesel exhaust and carbon black in F344 rats.

1 reference

12 December 2020

Morphologic changes in the lung during the lifespan of Fischer 344 rats

1 reference

12 December 2020

Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78

1 reference

12 December 2020

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

12 December 2020

4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro

1 reference

12 December 2020

Sialidase as a target for inhibitors of influenza virus replication

1 reference

12 December 2020

10.2165/00002018-199819030-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

0 references

1 reference